About RHEUMASENSE, INC.
Rheumasense empowers rheumatoid arthritis care with real-time, machine learning powered biomarker testing, delivering precise insights on disease activity for timely treatment adjustments and telemedicine support. The company is actively developing its diagnostic technology for clinical studies, aiming for FDA submission and future commercialization.
Real-time, machine learning powered biomarker testingLiquid Chromatography-Mass Spectrometry (LC-MS) biomarker testingAdvanced machine learning analytics for disease activity insightsAt-home blood collection kit with clinically validated testingDevelopment of diagnostic technology for clinical studies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RHEUMASENSE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.